Cannabinochromene (CBC, 1a) is the archetypal member of a class of more than twenty isoprenylated 5-hydroxy-7-alkyl(aralky)benzo[2H]pyranes first reported from Cannabis sativa L. but also occurring in unrelated plants (Rhododendron species) as well as liverworts and fungi. The chemistry, synthesis, and bioactivity of CBC (1a) is reviewed, highlighting its underexploited pharmacological potential and rich chemistry.
GaoniY., MechoulamR. (1966) Cannabichromene, a new active principle in hashish. Chemical Communications, 20–21.
2.
ClaussenU., SpulakF v, KorteF. (1966) Chemical classification of plants. XXXI. Hashish. 10. Cannabichromene, a new hashish component. Tetrahedron, 22, 1477–1479.
3.
ShoyamaY., FujitaT., YamauchiT., NishiokaI. (1968) Cannabis. II. Cannabichromenic acid, a genuine substance of cannabichromene. Chemical & Pharmaceutical Bulletin, 16, 1157–1158.
4.
TurnerC.E., HadleyK.W., HolleyJ.H., BilletsS., MoleM.L.Jr.. (1975) Constituents of Cannabis sativa L. VIII: Possible biological application of a new method to separate cannabidiol and cannabichromene. Journal of Pharmaceutical Sciences, 64, 810–814.
MazzoccantiG., IsmailO.H., D'AcquaricaI., VillaniC., ManzoC., WilcoxM., CavazziniA., GasparriniF. (2017) Cannabis through the looking glass: chemo- and enantio-selective separation of phytocannabinoids by enantioselective ultra high performance supercritical fluid chromatography. Chemical Communications, 53, 12262–12265.
7.
QuaghebeurK., CoosemansJ., ToppetS., CompernolleF. (1994) Cannabiorci- and 8-chlorocannabiorcichromenic acid as fungal antagonists from Cylindrocarpon olidum.Phytochemistry, 37, 159–161.
8.
HellwigV., NopperR., MaulerF., FreitagJ., Ji-KaiL., Zhi-HuiD., StadlerM. (2003) Activities of prenylphenol derivatives from fruitbodies of Albatrellus spp. on the human and rat vanilloid receptor 1 (VR1) and characterisation of the novel natural product, confluentin. Archiv der Pharmazie (Weinheim), 336, 119–126.
9.
IwataN., WangN., YaoX., KitanakaS. (2004) Structures and histamine release inhibitory effects of prenylated orcinol derivatives from Rhododendron dauricum.Journal of Natural Products, 67, 1106–1109.
10.
WangX., LiL., ZhuR., ZhangJ., ZhouJ., LouH. (2017) Bibenzyl-based meroterpenoid enantiomers from the Chinese liverwort Radula sumatrana.Journal of Natural Products, 80, 3143–3150.
11.
MorimotoS., KomatsuK., TauraF., ShoyamaY. (1998) Purification and characterization of cannabichromenic acid synthase from Cannabis sativa.Phytochemistry, 49, 1525–1529.
12.
de MeijerE.P., HammondK.M., MichelerM. (2009) The inheritance of chemical phenotype in Cannabis sativa L. (III): variation in cannabichromene proportion. Euphytica, 65, 293–611.
13.
GulW., GulS.W., ChandraS., LataH., IbrahimE.A., ElSohlyM.A. (2018) Detection and quantification of cannabinoids in extracts of Cannabis sativa roots using LC-MS/MS. Planta Medica. (in press, doi: 10.1055/s-0044-100798).
14.
OllisW.D., SutherlandI.O. (1961) Recent Development in the Chemistry of Natural Substances, p 84, Pergamon Press, Oxford 1961.
15.
KashiwadaY., YamazakiK., IkeshiroY., YamagishiT., FujiokaT., MihashiK., MizukiK., CosentinoM., FowkeK., Morris-NatschkeS.L., LeeK-H. (2001) Isolation of rhododaurichromanic acid B and the anti-HIV principles rhododaurichromanic acid A and rhododaurichromenic acid from Rhododendron dauricum.Tetrahedron, 57, 1559–1563.
16.
IjimaM., MunakataR., TakahashiH., KenmokuH., NakagawaR., KodamaT., AsakawaY., AbeI., YazakiK., KurosakiF., TauraF. (2017) Identification and characterization of daurichromenic acid synthase active in anti-HIV biosynthesis. Plant Physiology, 174, 2213–2230.
17.
OkadaM., SaitoK., WongC.P., LiC., WangD., IijimaM., TauraF., KurosakiF., AwakawaT., AbeI. (2017) Combinatorial biosynthesis of (+)-daurichromenic acid and its halogenated analogue. Organic Letters, 19, 3183–3186.
18.
(a) CrombieL., PonsfordR. (1968) Synthesis oif cannabinoids by terpenic cyclization. Chemical Communications, 894–895; (b) Crombie L.; Ponsford R. (1971) Synthesis of cannabinoids by pyridine catalyzed citral-olivetol condensation: synthesis and structure of cannabicyclol, cannabichromene (hashish extractives), citrilidene-cannabis, and related compounds. Journal of the Chemical Society (Section C), 796-804.
19.
KaneV.V., RazdanR.J. (1968) Constituents of hashish. A novel reaction of olivetol with citral in the presence of pyridine. Total synthesis of dl-cannabicyclol and dl-cannabichromene. Journal of the American Chemical Society, 90, 6551–6553.
20.
EisohlyH.N., TurnerC.E., ClarkA.M., EisohlyM.A. (1982) Synthesis and antimicrobial activities of certain cannabichromene and cannabigerol related compounds. Journal of Pharmaceutical Sciences, 71, 1319–1323.
21.
LuoG-Y, WuH., TnagY., LiH., YeomH-S, YangK., HsungR.P. (2015) A total synthesis of rhododaurichromanic acid A via an oxa-[3+3] annulation of resorcinols. Synthesis, 47, 2713–2720.
22.
(a) LeeY.R., XueW. (2005) Concise synthesis of biologically interesting cannabichromene, cannabichromenic acid, and daurichromenic acid. Bulletin of the Korean Chemical Society, 26, 1933–1936; (b) Li X, Lee YR (2014) Efficient and novel one-pot synthesis of polycycles bearing cyclols by FeCl3-promoted [2+2] cycloaddition: application to cannabicyclol, cannabicyclovarin, and ranhuadujanine A. Organic & Biomolecular Chemistry, 12, 1250-1257.
23.
TietzeL-F, KiedrowskiGv, BergerB. (1982) A new method of aromatization of cyclohexanone derivatives: Synthesis of cannabichromene. Synthesis, 683–684.
24.
LiuK., WoggonW-D. (2010) Enantioselective synthesis of daurichromenic acid and of confluentin. European Journal of Organic Chemistry, 1033–1036.
25.
CardilloG., CricchioR., MerliniL. (1968) Synthesis of D,L-cannabichromene, franklinone and other natural chromenes. Tetrahedron, 24, 4825–4831.
26.
MechoulamR., YagnitinskyB., GaoniY. (1968) Stereoelectronic factor in the chloranil dehydrogenation of cannabinoids. Total synthesis of dl-cannabichromene. Journal of the American Chemical Society, 24, 2418–2420.
27.
CrombieL., PonsfordR., ShaniA., YagnitinskyB., MechoulamR. (1968) Hashish components: Photochemical production of cannabicyclol from cannabichromene. Tetrahedron Letters, 5771–5772.
28.
YeomH-S, LiH., TangY., HsungR.P. (2013) Total syntheses of cannabicyclol, clusiacyclol A and B, iso-eriobrucinol A and B, and eriobrucinol. Organic Letters, 15, 3130–3133.
29.
YagenB., MechoulamR. (1969) Stereospecific cyclization and isomerizations of cannabichromene and related cannabinoids. Tetrahedron Letters, 5353–5356.
30.
GarciaA., BorchardtD., ChangA-E A., MarsellaM.J. (2009) Thermal isomerization of cannabinoid analogues. Journal of the American Chemical Society, 131, 16640–16641.
31.
HarveyD.J. (1985) Examination of a 140 year old ethanolic extract of Cannabis: Identification of new cannabitriol homologues and ethyl homologue of cannabinol. Proceeding of the Oxford Symposium on Cannabis, 23–30.
32.
DavisW.M., HatoumN.S. (1983) Neurobehavioral actions of cannabichromene and interactions with delta 9-tetrahydrocannabinol. General Pharmacology, 14, 247–252.
33.
DeLongG.T., WolfC.E., PoklisA., LichtmanA.H. (2010) Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol. Drug Alcohol Dependence, 112, 126–133.
34.
CascioM.G., PertweeR.G. (2014) Known pharmacological actions of nine nonpsychotropic phytocannabinoids. In Handbook of Cannabis.PertweeR.G. (Ed) Oxford Scholarship137–151.
35.
De PetrocellisL., LigrestiA., MorielloA.S., AllaràM., BisognoT., PetrosinoS., StottC.G., Di MarzoV. (2011) Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes. British Journal of Pharmacology, 163, 1479–1494.
36.
AppendinoG., GibbonsS., GianaA., PaganiA., GrassiG., StavriM., SmitE., RahmanM.M. (2008) Antibacterial cannabinoids from Cannabis sativa: A structure-activity study. Journal of Natural Products, 71, 1427–1430.
37.
NiliusB., AppendinoG., OwsianikG. (2012) The transient receptor potential channel TRPA1: from gene to pathophysiology. Pflugers Archiv. European Journal of Physiology, 464, 425–458.
38.
RomanoB., BorrelliF., FasolinoI., CapassoR., PiscitelliF., CascioM., PertweeR., CoppolaD., VassalloL., OrlandoP., Di MarzoV., IzzoA. (2013) The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitisBritish Journal of Pharmacology, 169, 213–229.
39.
IzzoA., CapassoR., AvielloG., BorrelliF., RomanoB., PiscitelliF., GalloL., CapassoF., OrlandoP., Di MarzoV. (2012) Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice. British Journal of Pharmacology, 166, 1444–1460.
40.
TurnerC.E., ElsohlyM.A. (1981) Biological activity of cannabichromene, its homologs and isomers. Journal of Clinical Pharmacology, 21, 283S–291S.
41.
OláhA., MarkovicsA., Szabó-PappJ., SzabóP.T., StottC., ZouboulisC., BíróT. (2016) Differential effectiveness of selected non-psychotropic phytocannabinoids on human sebocyte functions implicates their introduction in dry/seborrhoeic skin and acne treatment. Experimental Dermatology, 25, 701–707.
42.
PoklisJ.L., ThompsonC.C., LongK.A., LichtmanA.H., PoklisA. (2010) Disposition of cannabichromene, cannabidiol, and Δ9-tetrahydrocannabinol and its metabolites in mouse brain following marijuana inhalation determined by high-performance liquid chromatography-tandem mass spectrometry. Journal of Analytical Toxicology, 34, 516–20.
43.
HarveyD.J., BrownN.K. (1991) Identification of cannabichromene metabolites by mass spectrometry: identification of eight new dihydroxy metabolites in the rabbit. Biological Mass Spectrometry, 20, 275–285.
44.
BrownNK1, HarveyD.J. (1990) In vitro metabolism of cannabichromene in seven common laboratory animals. Drug Metablism and Disposition, 18, 1065–1070.
45.
HarveyD.J., BrownN.K. (1991) Comparative in vitro metabolism of the cannabinoids. Pharmacology Biochemical Behavior, 40, 533–540.
46.
LigrestiA., MorielloA.S., StarowiczK., MatiasI., PisantiS., De PetrocellisL., LaezzaC., PortellaG., BifulcoM., Di MarzoV. (2006) Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma. Journal of Pharmacology and Experimental Therapy, 318, 1375–1387.
47.
TauraF., IjimaM., KurosakiF. (2018) Daurichromenic acid and grifolic acid: Phytotoxic meroterpenoids that induce cell death in cell culture of their producerRhododendron dauricum. Plant Signal Behavior, 13 (in press, doi: 10.1080/15592324.2017.1422463).
